EEG in Dementia and Encephalopathy: Multimedia

References

1. Widagdo MM, Pierson JM, Helme RD. Age-related changes in qEEG during cognitive tasks. Int J Neurosci. Jul 1998;95(1-2):63-75. [Medline].

2. Stevens A, Kircher T. Cognitive decline unlike normal aging is associated with alterations of EEG temporo-spatial characteristics. Eur Arch Psychiatry Clin Neurosci. 1998;248(5):259-66. [Medline].

3. Stigsby B, Johannesson G, Ingvar DH. Regional EEG analysis and regional cerebral blood flow in Alzheimer's and Pick's diseases. Electroencephalogr Clin Neurophysiol. May 1981;51(5):537-47. [Medline].

4. Wada Y, Nanbu Y, Koshino Y. Reduced interhemispheric EEG coherence in Alzheimer disease: analysis during rest and photic stimulation. Alzheimer Dis Assoc Disord. Sep 1998;12(3):175-81. [Medline].

5. Jelic V, Blomberg M, Dierks T. EEG slowing and cerebrospinal fluid tau levels in patients with cognitive decline. Neuroreport. Jan 5 1998;9(1):157-60. [Medline].

6. Strik WK, Chiaramonti R, Muscas GC. Decreased EEG microstate duration and anteriorisation of the brain electrical fields in mild and moderate dementia of the Alzheimer type. Psychiatry Res. Oct 31 1997;75(3):183-91. [Medline].

7. Muller TJ, Thome J, Chiaramonti R. A comparison of qEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 1997;247(5):259-63. [Medline].

8. Akrofi K, Baker MC, O'Boyle MW, Schiffer RB. Clustering and modeling of EEG coherence features of Alzheimer's and mild cognitive impairment patients. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:1092-5. [Medline].

9. Siennicki-Lantz A, Lilja B, Rosen I. Cerebral blood flow in white matter is correlated with systolic blood pressure and EEG in senile dementia of the Alzheimer type. Dement Geriatr Cogn Disord. Jan-Feb 1998;9(1):29-38. [Medline].

10. Rodriguez G, Nobili F, Rocca G. Quantitative electroencephalography and regional cerebral blood flow: discriminant analysis between Alzheimer's patients and healthy controls. Dement Geriatr Cogn Disord. Sep-Oct 1998;9(5):274-83. [Medline].

11. Schreiter Gasser U, Rousson V, Hentschel F, Sattel H, Gasser T. Alzheimer disease versus mixed dementias: an EEG perspective. Clin Neurophysiol. Oct 2008;119(10):2255-9. [Medline].

12. Lehtovirta M, Partanen J, Kononen M. Spectral analysis of EEG in Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurobiol Aging. Jul-Aug 1996;17(4):523-6. [Medline].

13. Lehtovirta M, Partanen J, Kononen M, et al. A longitudinal quantitative EEG study of Alzheimer's disease: relation to apolipoprotein E polymorphism. Dement Geriatr Cogn Disord. Jan-Feb 2000;11(1):29-35. [Medline].

14. Briel RC, McKeith IG, Barker WA. EEG findings in dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry. Mar 1999;66(3):401-3. [Medline].

15. Ingvar DH, Philipson L. Distribution of cerebral blood flow in the dominant hemisphere during motor ideation and motor performance. Ann Neurol. Sep 1977;2(3):230-7. [Medline].

16. Gemignani A, Pietrini P, Murrell JR. Slow wave and rem sleep mechanisms are differently altered in hereditary pick disease associated with the TAU G389R mutation. Arch Ital Biol. Feb 2005;143(1):65-79. [Medline].

17. Gross RA, Spehlmann R, Daniels JC. Sleep disturbances in progressive supranuclear palsy. Electroencephalogr Clin Neurophysiol. Jul 1978;45(1):16-25. [Medline].

18. Su PC, Goldensohn ES. Progressive supranuclear palsy. Electroencephalographic studies. Arch Neurol. Sep 1973;29(3):l83-6. [Medline].

19. Tashiro K, Ogata K, Goto Y, Taniwaki T, Okayama A, Kira J. EEG findings in early-stage corticobasal degeneration and progressive supranuclear palsy: a retrospective study and literature review. Clin Neurophysiol. Oct 2006;117(10):2236-42. [Medline].

20. Roche S, Jacquesson JM, Destée A, Defebvre L, Derambure P, Monaca C. Sleep and vigilance in corticobasal degeneration: a descriptive study. Neurophysiol Clin. Aug-Sep 2007;37(4):261-4. [Medline].

21. Wszolek ZK, Lagerlund TD, Steg RE. Clinical neurophysiologic findings in patients with rapidly progressive familial parkinsonism and dementia with pallido-ponto-nigral degeneration. Electroencephalogr Clin Neurophysiol. Sep 1998;107(3):213-22. [Medline].

22. Serizawa K, Kamei S, Morita A, Hara M, Mizutani T, Yoshihashi H. Comparison of quantitative EEGs between Parkinson disease and age-adjusted normal controls. J Clin Neurophysiol. Dec 2008;25(6):361-6. [Medline].

23. Obraztsova ER, Sharova EV, Zaitsev OS. Characteristics of brain bioelectrical activity in post-traumatic Korsakov's syndrome. Neurosci Behav Physiol. Oct 2004;34(8):825-31. [Medline].

24. Kuroda Y, Ikeda A, Kurohara K. Occurrence of paroxysmal synchronous EEG discharges in subcortical arteriosclerotic encephalopathy (Binswanger's disease). Intern Med. Mar 1993;32(3):243-6. [Medline].

25. Dzialek E, Szymanska R, Bogucki A. [The electroencephalographic image in Binswanger's subcortical arteriosclerotic encephalopathy]. Neurol Neurochir Pol. May-Jun 1989;23(3):214-9. [Medline].

26. Plachinda IuI, Belonog RP, Noshchenko AG. [Correlations of cognition disorders and the EEG data in elderly patients with circulatory encephalopathy]. Zh Nevropatol Psikhiatr Im S S Korsakova. 1992;92(1):34-8. [Medline].

27. Iznak AF, Gavrilova SI, Zhigulskaia SE. [Quantitative EEG in early and differential diagnosis of mild dementia of different genesis]. Vestn Ross Akad Med Nauk. 1999;(1):11-6. [Medline].

28. Kushner MJ, Hauser WA. Transient global amnesia: a case-control study. Ann Neurol. Dec 1985;18(6):684-91. [Medline].

29. Thomke F, Marx JJ, Sauer O. Observations on comatose survivors of cardiopulmonary resuscitation with generalized myoclonus. BMC Neurol. 2005;5:14. [Medline].

30. Ikeda A, Klem GH, Luders HO. Metabolic, infectious, and hereditary encephalopathies. In: Ebersole JS, Pedley TA. Current Practice of Clinical Electroencpehalography. 3rd Ed. Lippincott Williams & Wilkins; 2003:370-371.

31. Boyd SG, Harden A, Egger J. Progressive neuronal degeneration of childhood with liver disease (Alpers' disease): characteristic neurophysiological features. Neuropediatrics. May 1986;17(2):75-80. [Medline].

32. Al-Mateen M, Philippart M, Shields WD. Rett syndrome. A commonly overlooked progressive encephalopathy in girls. Am J Dis Child. Aug 1986;140(8):761-5. [Medline].

33. McIntosh RP, Simatos D, Weston HJ, et al. Rett syndrome: case reports and review. N Z Med J. Mar 28 1990;103(886):122-5. [Medline].

34. Aoki T, Kobayashi K, Jibiki I. An autopsied case of Creutzfeldt-Jakob disease with the lateral geniculate body lesion showing antagonizing correlation between periodic synchronous discharges and photically induced giant evoked responses. Psychiatry Clin Neurosci. Jun 1998;52(3):333-7. [Medline].

35. Hansen HC, Zschocke S, Sturenburg HJ. Clinical changes and EEG patterns preceding the onset of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Acta Neurol Scand. Feb 1998;97(2):99-106. [Medline].

36. Steinhoff BJ, Kropp S, Riedemann C. [Elecroencephalographic charactistics of Creutzfeldt-Jakob disease and its differential diagnosis]. Fortschr Neurol Psychiatr. Aug 1998;66(8):357-65. [Medline].

37. Lee KE, Loh NK, Tan AK. Creutzfeldt-Jakob disease presenting with visual blurring, diplopia and visual loss: Heidenhain's variant. Ann Acad Med Singapore. Nov 1998;27(6):854-6. [Medline].

38. Aguglia U, Farnarier G, Tinuper P. Subacute spongiform encephalopathy with periodic paroxysmal activities: clinical evolution and serial EEG findings in 20 cases. Clin Electroencephalogr. Jul 1987;18(3):147-58. [Medline].

39. Thomas P, Borg M. Reversible myoclonic encephalopathy revealing the AIDS-dementia complex. Electroencephalogr Clin Neurophysiol. Feb 1994;90(2):166-9. [Medline].

40. Canafoglia L, Panzica F, Franceschetti S. Rhythmic cortical myoclonus in a case of HIV-related encephalopathy. Mov Disord. Dec 2003;18(12):1533-8. [Medline].

41. Sinha S, Satishchandra P. Nervous system involvement in asymptomatic HIV seropositive individuals: a cognitive and electrophysiological study. Neurol India. Dec 2003;51(4):466-9. [Medline].

42. Polich J, Ilan A, Poceta JS. Neuroelectric assessment of HIV: EEG, ERP, and viral load. Int J Psychophysiol. Oct 2000;38(1):97-108. [Medline].

43. Ferrari S, Monaco S, Morbin M. HIV-associated PML presenting as epilepsia partialis continua. J Neurol Sci. Dec 11 1998;161(2):180-4. [Medline].

44. Diehl B, Evers S, Sylvester E. Routine electroencephalogram in follow-up of patients with HIV infections of different stages. A long-term study. Nervenarzt. Jun 1998;69(6):485-9. [Medline].

45. Hsieh WB, Chiu NC, Hu KC, Ho CS, Huang FY. Outcome of herpes simplex encephalitis in children. J Microbiol Immunol Infect. Feb 2007;40(1):34-8. [Medline].

46. Al-Shekhlee A, Kocharian N, Suarez JJ. Re-evaluating the diagnostic methods in herpes simplex encephalitis. Herpes. May 2006;13(1):17-9. [Medline].

47. Wasay M, Diaz-Arrastia R, Suss RA. St Louis encephalitis: a review of 11 cases in a 1995 Dallas, Tex, epidemic. Arch Neurol. Jan 2000;57(1):114-8. [Medline].

48. Flaherty MP, O'Flaherty SJ. Neurological deterioration following head injury: the eyes had it. J Paediatr Child Health. Apr 1998;34(2):202-5. [Medline].

49. Koppel BS, Poon TP, Khandji A, et al. Subacute sclerosing panencephalitis and acquired immunodeficiency syndrome: role of electroencephalography and magnetic resonance imaging. J Neuroimaging. Apr 1996;6(2):122-5. [Medline].

50. Takahashi M, Kubota F, Nishi Y. Persistent synchronous periodic discharges caused by anoxic encephalopathy due to cardiopulmonary arrest. Clin Electroencephalogr. Oct 1993;24(4):166-72. [Medline].

51. Fernandez-Torre JL, Gonzalez-Rato J, Martinez-Martinez M. Acute stimulus-sensitive postanoxic myoclonus: description of a case. Clin EEG Neurosci. Jul 2005;36(3):199-201. [Medline].

52. Young GB, Doig GS. Continuous EEG monitoring in comatose intensive care patients: epileptiform activity in etiologically distinct groups. Neurocrit Care. 2005;2(1):5-10. [Medline].

53. Kameda K, Itoh N, Nakayama H. Frontal intermittent rhythmic delta activity (FIRDA) in pituitary adenoma. Clin Electroencephalogr. Jul 1995;26(3):173-9. [Medline].

54. Juvarra G, Bettoni L, Olivieri MF, et al. Hypercalcemic encephalopathy in the course of hyperthyroidism. Eur Neurol. 1985;24(2):121-7. [Medline].

55. Wang CP, Hsieh PF, Chen CC. Hyperglycemia with occipital seizures: images and visual evoked potentials. Epilepsia. Jul 2005;46(7):1140-4. [Medline].

56. Yalnizoglu D, Sari N, Turanli G. Neurophysiologic features in glutaric aciduria type I. Turk J Pediatr. Apr-Jun 2005;47(2):153-8. [Medline].

57. Flaten TP, Alfrey AC, Birchall JD, et al. Status and future concerns of clinical and environmental aluminum toxicology. J Toxicol Environ Health. Aug 30 1996;48(6):527-41. [Medline].

58. Kuzuhara S, Ohkoshi N, Kanemaru K, et al. Subacute leucoencephalopathy induced by carmofur, a 5-fluorouracil derivative. J Neurol. Aug 1987;234(6):365-70. [Medline].

59. Maganti R, Jolin D, Rishi D. Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function. Epilepsy Behav. Feb 2006;8(1):312-4. [Medline].

60. Rowden AK, Holstege CP, Huff JS, et al. Lead Encephalopathy. eMedicine from WebMD. Available at http://emedicine.medscape.com/article/1174752-overview. Accessed November 11, 2009.

61. Karri SK, Saper RB, Kales SN. Lead encephalopathy due to traditional medicines. Curr Drug Saf. Jan 2008;3(1):54-9. [Medline].

62. Stewart WF, Schwartz BS, Davatzikos C, Shen D, Liu D, Wu X, et al. Past adult lead exposure is linked to neurodegeneration measured by brain MRI. Neurology. May 23 2006;66(10):1476-84. [Medline].

63. Yip KK, Yeung WT. Lithium overdose causing non-convulsive status epilepticus--the importance of lithium levels and the electroencephalography in diagnosis. Hong Kong Med J. Dec 2007;13(6):471-4. [Medline].

64. Bellesi M, Passamonti L, Silvestrini M, Bartolini M, Provinciali L. Non-convulsive status epilepticus during lithium treatment at therapeutic doses. Neurol Sci. Feb 2006;26(6):444-6. [Medline].

65. Herrero Hernandez E, Discalzi G, Dassi P. Manganese intoxication: the cause of an inexplicable epileptic syndrome in a 3 year old child. Neurotoxicology. Aug 2003;24(4-5):633-9. [Medline].

66. Bauer J, Cooper-Mahkorn D. Tiagabine: efficacy and safety in partial seizures - current status. Neuropsychiatr Dis Treat. Aug 2008;4(4):731-6. [Medline].

67. Kellinghaus C, Dziewas R, Lüdemann P. Tiagabine-related non-convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature. Seizure. Jun 2002;11(4):243-9. [Medline].

68. Vinton A, Kornberg AJ, Cowley M, Matkovic Z, Kilpatrick C, O'Brien TJ. Tiagabine-induced generalised non convulsive status epilepticus in patients with lesional focal epilepsy. J Clin Neurosci. Feb 2005;12(2):128-33. [Medline].

69. Panda S, Radhakrishnan K. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure. J Assoc Physicians India. Sep 2004;52:746-8. [Medline].

70. Segura-Bruna N, Rodriguez-Campello A, Puente V, Roquer J. Valproate-induced hyperammonemic encephalopathy. Acta Neurol Scand. Jul 2006;114(1):1-7. [Medline].

71. Cheung E, Wong V, Fung CW. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report. J Child Neurol. Feb 2005;20(2):157-60. [Medline].

72. Adams DH, Ponsford S, Gunson B. Neurological complications following liver transplantation. Lancet. Apr 25 1987;1(8539):949-51. [Medline].

73. Hietaharju A, Jaaskelainen S, Hietarinta M. Central nervous system involvement and psychiatric manifestations in systemic sclerosis (scleroderma): clinical and neurophysiological evaluation. Acta Neurol Scand. May 1993;87(5):382-7. [Medline].

74. Ghika-Schmid F, Ghika J, Regli F. Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition?. Mov Disord. Sep 1996;11(5):555-62. [Medline].

75. Kothbauer-Margreiter I, Sturzenegger M, Komor J. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol. Aug 1996;243(8):585-93. [Medline].

76. Foley JM, Watson CW, Adams RD. Significance of electroencephalographic changes in hepatic coma. Trans Am Neurol Assoc. 1950;75:161-165.

77. Blatt I, Brenner RP. Triphasic waves in a psychiatric population: a retrospective study. J Clin Neurophysiol. Jul 1996;13(4):324-9. [Medline].

78. Aguglia U, Gambardella A, Oliveri RL, et al. Nonmetabolic causes of triphasic waves: a reappraisal. Clin Electroencephalogr. Jul 1990;21(3):120-5. [Medline].

79. Sundaram MB, Blume WT. Triphasic waves: clinical correlates and morphology. Can J Neurol Sci. May 1987;14(2):136-40. [Medline].

80. Bittenbender JB, Quadfasel FA. Rigid and akinetic forms of Huntington's chorea. Arch Neurol (Chicago). 1962;7:275-288.

81. Drazkowski J. Using EEG in a consultative role. Semin Neurol. Sep 2003;23(3):295-306. [Medline].

82. Fossi S, Amantini A, Grippo A. Anoxic-ischemic alpha coma: prognostic significance of the incomplete variant. Neurol Sci. Feb 2004;24(6):397-400. [Medline].

83. Foster MG. The in vivo antifungal effects of benomyl on non-target soil fungi. Bull Environ Contam Toxicol. Sep 1975;14(3):353-60. [Medline].

84. Hallett M, Wilkins DE. Myoclonus in Alzheimer's disease and minipolymyoclonus. Adv Neurol. 1986;43:399-405. [Medline].

85. Hill D. The EEG in organic disease. Proc R Soc Med. 1948;41:242-248.

86. Ingvar DH. History of brain imaging in psychiatry. Dement Geriatr Cogn Disord. Mar-Apr 1997;8(2):66-72. [Medline].

87. Ingvar DH. [The cerebral ideogram]. Encephale. 1977;3(1):5-33. [Medline].

88. Isozumi K, Fukuuchi Y, Tanaka K, et al. A MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) mtDNA mutation that induces subacute dementia which mimics Creutzfeldt-Jakob disease. Intern Med. Sep 1994;33(9):543-6. [Medline].

89. Lance JW. Action myoclonus, Ramsay Hunt syndrome, and other cerebellar myoclonic syndromes. Adv Neurol. 1986;43:33-55. [Medline].

90. Locatelli T, Cursi M, Liberati D. EEG coherence in Alzheimer''s disease. Electroencephalogr Clin Neurophysiol. Mar 1998;106(3):229-37. [Medline].

91. Nuwer M. Assessment of digital EEG, quantitative EEG, and EEG brain mapping: report of the American Academy of Neurology and the American Clinical Neurophysiology Society. Neurology. Jul 1997;49(1):277-92. [Medline].

92. Rodriguez G, Nobili F, Copello F. 99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: a correlative study. J Nucl Med. Apr 1999;40(4):522-9. [Medline].

93. Schwab RS, England AC, Peterson E. Akinesia in Parkinson's disease. Neurology. 1959;9:65-72.

94. Schwab RS, England AC, Peterson E. Comparison of EEG findings in Parkinson's disease. Electroenceph Clin Neurophysiol. 1958;10:186.

95. Tatum WO 4th, Ross J, Cole AJ. Epileptic pseudodementia. Neurology. May 1998;50(5):1472-5. [Medline].

96. Xu CY. [An EEG evaluation in diagnosing subacute spongiform encephalopathy]. Chung Hua Shen Ching Ching Shen Ko Tsa Chih. Feb 1989;22(1):37-8, 63. [Medline].

Further Reading

Keywords

electroencephalography, electroencephalogram, electroencephalographic, quantitative EEG, QEEG, cognitive decline, cognitive impairment, aging, Alzheimer disease, Parkinson disease, CJD, encephalopathy, encephalitis, PLEDs, GPED, triphasic waves

Contributor Information and Disclosures

Author

Eli S Neiman, DO, Assistant Professor of Neurology, Comprehensive Epilepsy Center, New Jersey Neuroscience Institute-JFK Medical Center, Edison, NJ
Eli S Neiman, DO is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, American Medical Association, and American Osteopathic Association
Disclosure: Nothing to disclose.

Coauthor(s)

Philip A Hanna, MD, Associate Professor, Department of Neuroscience, Seton Hall University School of Graduate Medical Education; Residency Program Director, New Jersey Neuroscience Institute, JFK Medical Center; Neurology Director, Huntington's Disease Unit, JFK Hartwyck-Cedarbrook
Philip A Hanna, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, and Movement Disorders Society
Disclosure: Nothing to disclose.

Medical Editor

Erasmo A Passaro, MD, Director, Comprehensive Epilepsy Program/Clinical Neurophysiology Lab, Bayfront Medical Center Florida Center for Neurology
Erasmo A Passaro, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, American Medical Association, and American Society of Neuroimaging
Disclosure: Glaxo Smith Kline Honoraria Speaking and teaching; UCB Honoraria Speaking and teaching; Pfizer Honoraria Speaking and teaching; Takeda Honoraria Speaking and teaching

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.